Found 1727 matching trials
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of stereotactic b...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy PHASE2 Radiotherapy can activate local and systemic immune responses through a var...
Show More Location
Multiple Locations
Learn More & Join Trial
SIRT With Tremelimumab and Durvalumab for Resectable HCC PHASE1 The goal of this research study is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC PHASE2 This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Pembrolizumab PHASE2 This multi-institutional, phase 2 clinical trial is studying two doses of p...
Show More Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial